1-2 of 2
David Assouline, MD
Close
Sort by
Journal Articles

Final Results of the RiPAD+C Regimen Including Velcade In Front Line Therapy for Elderly Patients with Mantle Cell Lymphoma. A Phase II Prospective Study of the GOELAMS Group.

Remy Gressin, MD, Roch Houot, Mario Ojeda Uribe, Christiane Mounier, Krimo Bouabdallah, Magda Alexis, MD, Delphine Senecal, Marie Pierre Molles, Olivier Tournilhac, MD, PhD, Sophie Park, Philippe Rodon, MD, Abderrazak El Yamani, Laurent Sutton, Bruno Lioure, David Assouline, MD, Jean-Luc Harousseau, HerveĢ Maisonneuve, Sylvie Caulet Maugendre, Steven Le Gouill
Journal: Blood
Blood (2010) 116 (21): 2791.
https://doi.org/10.1182/blood.V116.21.2791.2791
Published: 2010
Journal Articles

Interim Results of the RiPAD+C Regimen Including Velcade in Front Line Therapy for Elderly Patients with Mantle Cell Lymphoma. A Phase II Prospective Study of the GOELAMS Group.

Remy Gressin, MD, Sylvie caulet Maugendre, MD, Steven Le Gouill, MD, Mario ojeda Uribe, MD, Magda Alexis Vigier, MD, Krimo Bouabdallah, Christiane Mounier, Olivier Tournilhac, MD, Philippe Rodon, MD, Abderrazak El Yamani, Laurent Sutton, Delphine Senecal, MD, Bruno Lioure, MD, David Assouline, MD, Annie Le Mevel, MD, Bruno Villemagne, MD, Charles Dauriac, MD, Martine Gardembas, MD, Sophie Park, MD, Thierry Lamy, PhD
Journal: Blood
Blood (2008) 112 (11): 1575.
https://doi.org/10.1182/blood.V112.11.1575.1575
Published: 2008